Health Care & Insurance

ARTICLES

Alzheimer’s drug makes Avanir potential Lilly target

Eli Lilly and Co. would be a logical acquirer for the maker of a drug that could treat agitation in Alzheimer’s patients.
Read More

Health care overhaul doubts ease for insurers

Health insurers such as WellPoint Inc. entered last fall cautious about a major coverage expansion initiated by the health care overhaul, but are finding the challenges more manageable than expected.
Read More

Eli Lilly donates $12.7 million to United Way

The donation represents the giving of employees and retirees of Lilly and Elanco Animal Health in the U.S. and Puerto Rico, plus a matching contribution from the Lilly Foundation.
Read More

WellPoint profit dips, but rising membership boosts outlook

Enrollment in WellPoint’s health plans increased by 259,000 members in the third quarter. Growth came in WellPoint’s employer and Medicaid plans, while its individual health plans declined by 108,000.
Read More

CNO reports lower third-quarter profit, revenue

The Carmel-based insurance holding company had profit of $117.4 million in the period ended Sept. 30, down from $283 million in last year's third quarter. Revenue fell 11 percent, to $967 million.
Read More

Central Indiana doctor faces prescription drug charges

Dr. Eric Jones of Pendleton was arrested Tuesday at his general family practice about 25 miles northeast of Indianapolis.
Read More

Takeda, Lilly win 99-percent cut in Actos damages award

Judge Rebecca Doherty in Lafayette, Louisiana, said the jury's decision to order Takeda to pay $6 billion and Lilly $3 billion was excessive and should be reduced to a total of $36.8 million.
Read More

Seals Ambulance sells to Tennessee firm

Seals Ambulance, with 325 workers and nearly $13 million in revenue, will be acquired by Priority Ambulance, but keep its local leadership and name.
Read More

Mayors at meth summit call for medication controls

Some of Indiana's mayors and law enforcement officials are urging lawmakers to combat the state's methamphetamine scourge by making some cold medications available only by prescription.
Read More

Lilly adds $375M to Zymeworks partnership

Eli Lilly and Co. and Zymeworks said Wednesday that they are expanding a cancer drug development partnership.
Read More